BSE Live
Apr 15, 16:01Prev. Close
812.90
Open Price
848.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 15, 15:59Prev. Close
814.20
Open Price
844.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
866.30 (88)
| Cash Flow of Windlas Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 79.39 | 77.02 | 57.06 | 46.04 | 11.18 | |
| Net CashFlow From Operating Activities | 68.23 | 108.91 | 60.98 | 9.00 | 11.45 | |
| Net Cash Used In Investing Activities | -74.06 | -92.07 | -14.11 | -154.31 | -20.19 | |
| Net Cash Used From Financing Activities | 1.01 | -15.29 | -43.74 | 130.09 | 0.78 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 5.67 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -4.82 | 1.56 | 3.13 | -15.22 | -2.30 | |
| Cash And Cash Equivalents Begin of Year | 5.24 | 3.69 | 0.55 | 15.78 | 18.08 | |
| Cash And Cash Equivalents End Of Year | 0.42 | 5.24 | 3.69 | 0.55 | 15.78 |
18.02.2026
Windlas Biotech Consolidated December 2025 Net Sales at Rs 233.10 crore, up 19.53% Y-o-Y
10.02.2026
Windlas Biotech Standalone December 2025 Net Sales at Rs 233.10 crore, up 19.53% Y-o-Y
12.11.2025
Windlas Biotech Standalone September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
07.11.2025
Windlas Biotech Consolidated September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
18.02.2026
Windlas Biotech Consolidated December 2025 Net Sales at Rs 233.10 crore, up 19.53% Y-o-Y
10.02.2026
Windlas Biotech Standalone December 2025 Net Sales at Rs 233.10 crore, up 19.53% Y-o-Y
12.11.2025
Windlas Biotech Standalone September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y
07.11.2025
Windlas Biotech Consolidated September 2025 Net Sales at Rs 222.40 crore, up 18.93% Y-o-Y